BAZ2A and bladder transitional cell carcinoma: The results showed that In Bladder Urothelial Carcinoma (BLCA), CHOL, ESCA, HNSC, KIRC, KIRP, LIHC, Lung squamous cell carcinoma (LUSC), PRAD, In STAD, the expression level of BAZ2A was significantly increased in cancer tissues (Fig. 1B, Table 1).Finally, combined with Fig. 1A,B, we found that BAZ2A showed high expression levels in multiple cancer species in both paired and unpaired samples.